Sridhar Kosaraju
CIK 1651325 · President · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$74.84M
Companies
3
Total Filings
62
Lifetime Open-Market Net
-$17.39M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 3 of 7
62 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-27 | NEVRO CORP (NVRO) Delisted | Grant (A) | +4,155 | $0 | EDGAR |
| 2022-05-17 | TXG | Exer (M) | +15,000 | $172.2K | EDGAR |
| 2022-04-04 | NEVRO CORP (NVRO) Delisted | Grant (A) | +190 | $0 | EDGAR |
| 2022-01-04 | TXG | Sell (S) | −1,500 | -$225.6K | EDGAR |
| 2022-01-04 | NEVRO CORP (NVRO) Delisted | Grant (A) | +169 | $0 | EDGAR |
| 2021-11-29 | TXG | Sell (S) | −1,500 | -$225.1K | EDGAR |
| 2021-10-27 | TXG | Sell (S) | −1,500 | -$249.5K | EDGAR |
| 2021-09-24 | TXG | Sell (S) | −1,500 | -$238.6K | EDGAR |
| 2021-09-02 | NEVRO CORP (NVRO) Delisted | Grant (A) | +2,459 | $0 | EDGAR |
| 2021-08-25 | TXG | Sell (S) | −1,500 | -$243.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.